M&A
GSK Invests in Biotech Developing Covid-19 Treatments
By Lisa Botter
|
Published: April 16th, 2020
The British drugmaker said it would make an equity investment of $250 million in Vir.
Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.